Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manteia is a medical technology company specializing in artificial intelligence-driven solutions for radiotherapy and oncology. Founded in 2017, the company develops deep learning-based software platforms, such as AccuContour and AccuPlan, which automate critical clinical tasks like organ-at-risk contouring and treatment planning. These tools are designed to enhance the precision of radiation therapy while significantly reducing the time required for clinical workflows. Manteia's technology is utilized by hundreds of hospitals worldwide, supporting the transition toward more efficient and personalized adaptive radiotherapy. The company focuses on bridging the gap between advanced AI research and practical clinical application in cancer care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manteia.